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Abstract
Introduction: Maternal mortality is high in developing countries, but there are few data in high-risk groups such as migrants
and refugees in malaria-endemic areas. Trends in maternal mortality were followed over 25 years in antenatal clinics
prospectively established in an area with low seasonal transmission on the north-western border of Thailand.
Methods and Findings: All medical records from women who attended the Shoklo Malaria Research Unit antenatal clinics
from 12th May 1986 to 31st December 2010 were reviewed, and maternal death records were analyzed for causality. There
were 71 pregnancy-related deaths recorded amongst 50,981 women who attended antenatal care at least once. Three were
suicide and excluded from the analysis as incidental deaths. The estimated maternal mortality ratio (MMR) overall was 184
(95%CI 150–230) per 100,000 live births. In camps for displaced persons there has been a six-fold decline in the MMR from
499 (95%CI 200–780) in 1986–90 to 79 (40–170) in 2006–10, p,0.05. In migrants from adjacent Myanmar the decline in
MMR was less significant: 588 (100–3260) to 252 (150–430) from 1996–2000 to 2006–2010. Mortality from P.falciparum
malaria in pregnancy dropped sharply with the introduction of systematic screening and treatment and continued to
decline with the reduction in the incidence of malaria in the communities. P.vivax was not a cause of maternal death in this
population. Infection (non-puerperal sepsis and P.falciparum malaria) accounted for 39.7 (27/68) % of all deaths.
Conclusions: Frequent antenatal clinic screening allows early detection and treatment of falciparum malaria and
substantially reduces maternal mortality from P.falciparum malaria. No significant decline has been observed in deaths from
sepsis or other causes in refugee and migrant women on the Thai–Myanmar border.
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Introduction
Of all mortality rates none has a greater disparity than the
maternal mortality between women living in the least developed
countries and those living in industrialized countries. Based on
data from 2005, the average lifetime risk of dying from
complications related to pregnancy or childbirth was 300 times
higher in least developed countries. [1] Global maternal mortality
has decreased from 422 (358–505) in 1980 to 320 (272–388) in
1990, and was 251 (221–289) per 100 000 livebirths in 2008. [2]
Most of this gain comes from a few countries, such as China and is
associated with remarkable economic growth. Much of the
reduction in maternal mortality in East Asia is attributed to
improvements in obstetric care, and a shift away from home
births. [3] In contrast, maternal mortality has increased in other
countries, particularly those affected by conflict or high rates of
HIV infection, mostly in Sub-Saharan Africa.
Thailand has a population of over 60 million. It has experienced
significant improvements in population health and a decline in
maternal and child mortality. [4] This has been achieved largely
by substantial investment in the district health system since 1975.
[5,6] The relatively low maternal mortality ratio [95%CI] (per
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100,000 live births) in Thailand: 50 [31–78], 63 [41–89] and 48
[32–68], in 1990, 2000 and 2008, contrasts with estimates from
Thailand’s western neighbor, Myanmar: 420 [23–470], 290 [170–
510] and 240 [140–410], in the same years [7].
In rural areas of Southeast Asia malaria transmission of
P.falciparum and P.vivax is low and seasonal. In Prapokklao
Regional Hospital in Chantaburi on Thailand’s eastern border
with Cambodia, in the early 1980s, malaria was the most common
cause of maternal mortality. The development of an ‘‘action for
survival’’ program dedicated to the care of pregnant women with
malaria resulted in a dramatic reduction in maternal deaths from
341 to 54/100,000 live births from 1981 to 1986. [8] In 2008, the
malaria attributable maternal mortalities in Thailand and
Myanmar were 0.4 [0.1–0.9] and 34 [17–56] per 100,000,
respectively [7].
Accurate data are crucial for monitoring progress towards the
millennium development goal 5 (MDG), to: ‘‘Reduce by three
quarters, between 1990 and 2015, the maternal mortality ratio’’
[9], and MDG 6c: to: ‘‘Have halted by 2015 and begun to reverse
the incidence of malaria and other major diseases’’. Such data are
difficult to obtain in resource poor settings where maternal
mortality is highest in high risk groups such refugee and migrant
populations. [10] Surveys in active conflict zones in eastern
Myanmar in 2002–3, suggested a maternal mortality as high as
1,000 to 1,200 per 100,000 live births [8] but causes were not
determined. [11] Malaria was undoubtedly a significant contrib-
utor: in 2008, 56% of pregnant women surveyed in eastern
Myanmar, reported that they had a malaria test (rapid test) in their
last pregnancy, of which 12% were positive [12].
The Shoklo Malaria Research Unit (SMRU) is based on the
north-western border of Thailand and provides health care to
refugee and migrant populations. In response to an estimated
malaria maternal mortality from P.falciparum malaria of 1% (5/
500) in 1985–86 i.e. a single cause equating to a maternal
mortality ratio of 1,000 per 100,000 live births, a system of weekly
antenatal clinics offering frequent screening for early detection and
treatment of malaria was established. [13] This manuscript reports
on maternal deaths within that system which has been available to
refugees for 25 years (1986–2010) and to migrant women for 12
years (1998–2010).
Methods
Ethics Statement
Permission from each individual woman for their information
from pregnancy records to be stored and used for research was not
obtained because the records were anonymised. Ethical approval
for retrospective analysis of pregnancy records was provided by the
Oxford Tropical Research Ethics Committee (OXTREC 28–09).
Study Area and Population
The SMRU is situated on the north-western border of Thailand
(Figure 1). Malaria transmission is low and seasonal in this area
and has been described well elsewhere. [14] Briefly, symptomatic
malaria occurs in all age groups and pregnant women are at
Figure 1. Study area sites of migrant and refugee clinics on the Thai-Myanmar border. Sites for migrants denoted by circles (orange) and
refugee by squares (blue).
doi:10.1371/journal.pone.0040244.g001
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higher risk of severe malaria than non-pregnant women of the
same age. [15] Both P.falciparum and P.vivax malaria have been
shown to reduce birth weight in this setting. [13,16] In a
randomized controlled trial of insecticide treated nets in pregnant
women in this area, no significant reduction in malaria episodes
was observed [17–19]. There are no reliable malaria preventative
measures [17–19] for pregnant women and treatment options are
limited because of a high prevalence of multidrug resistant P.
falciparum and because primaquine for radical cure of vivax malaria
is contraindicated in pregnancy. [20] Pregnant women have been
encouraged to attend clinics providing antenatal care (ANC) for
the early detection and treatment of malaria since 1986 for
refugees and since 1998 for migrants (Figure 1).
Refugee camps were established on the western border of
Thailand in 1984 as ethnic Myanmar, mostly of Karen origin, fled
armed conflict. Shoklo was formerly the largest camp on the
border with a population at its peak of approximately 9,000. In
1995–6, Shoklo and other smaller camps were closed and the
population regrouped into Maela camp, currently the largest
settlement, with an estimated population of 45,000. Non-
government organizations providing education and the majority
of healthcare and the Thai-Burma Border Consortium providing
food rations and building materials have supported the refugee
population. Approximately 5% of women attending antenatal care
services in the refugee camp come from surrounding villages. The
acute complex emergency conditions of the early years of the
refugee camp changed to the more stable, chronic refugee
situation of today. The migrant communities are mostly involved
in seasonal forest and agricultural work along the border, and
women frequently move from the area before the pregnancy
outcome is known. Provision of health care on the Myanmar side
of the border has been non-existent or uncoordinated and access
to the Thai system is limited by language, security, and
transportation difficulties.
Antenatal Care and Delivery
Women are encouraged to attend antenatal care as soon as they
are aware of their pregnancy. More than 90% of pregnant women
in the camps for displaced persons where SMRU operates (current
population 45,000) have attended for regular malaria screening.
[13] At the first consultation, an obstetric and medical history is
recorded, and a clinical examination performed. At each weekly
visit a finger prick blood sample is examined for malaria by trained
microscopists. Haematocrit measured every two weeks com-
menced in 1991. Women are also encouraged to attend if they
feel unwell at any time between routine consultations to any of the
SMRU facilities which are open 24 hours per day. Malaria and
other medical problems are treated free of charge. There is no
presumptive treatment of malaria. Women receive thiamine
(Vitamin B1, 100 mg daily) to prevent infant mortality from
beri-beri [21], and ferrous sulphate and folic acid at prophylactic
or treatment doses. Testing for HIV for the prevention of mother
to child transmission has been available since 2001 in the refugee
population and 2008 in migrants. The seroprevalence of syphilis
and HIV remain very low in this area: ,0.5% for both [22].
In the early years of the refugee camps, close to 100% of
deliveries were at home with traditional birth attendants and only
problem cases delivered in SMRU or were referred to the Thai
Public Hospital. Delivery with the assistance of trained midwives
at SMRU was promoted with increasing effort from 1994 onwards
and place of delivery (home, SMRU or Thai hospital) was added
to routine data collection. Abortion is prohibited in Thailand and
was not provided by medical facilities but some traditional birth
attendants are reported to provide unsafe termination practices.
[23] Pregnancy dating relied on Dubowitz gestational age (GA)
assessment and fundal height before 2001 and was then replaced
by ultrasound dating. [24–26] Local microbiological services were
established in 2008.
SMRU is staffed by locally trained medical assistants, nurses,
midwives, sonographers, laboratory technicians, home-visitors,
support staff and a small number of expatriate doctors. As just
under half of the pregnant women are literate a large component
of the work involves verbal explanation using a mosaic of
languages, mostly Sgaw Karen, Poe Karen, Burmese and English
[27].
Anonymized medical records of refugee and migrant women
who attended SMRU antenatal clinics between the 12th May 1986
and 31st Dec 2010, were examined. The primary objective of this
work was to determine the trends in maternal death across time,
and the causes of death in refugee and migrant women. There
were no exclusion criteria of this population based study.
Cause of Maternal Death
In this study the ICD-10 definition of maternal death was used:
‘‘the death of a woman while pregnant or within 42 days of
termination of pregnancy from any cause related to pregnancy or
its management, but not from accidental or incidental causes’’.
[28] Direct maternal deaths were defined if obstetric related,
indirect deaths if aggravated by pregnancy and incidental deaths if
unrelated to pregnancy. The maternal mortality ratio (MMR) was
defined as the number of maternal deaths (direct and indirect) per
100,000 live births. Incidental deaths were not included in
maternal mortality calculations [2].
Autopsy was not available whether death occurred at SMRU or
in the Thailand referral hospital. In the case of a death at home,
interview for a verbal autopsy with a close family member/s, and
where possible the traditional birth attendant present at the time of
death, was sought. Assignment of the cause of death was based on
collation of the medical and obstetric data from the records,
clinical symptoms and signs, laboratory results, and notes from
interviews with family members, independently reviewed by 3
doctors (RM, MB, MR). The results were compared and the
doctors met to try to resolve the discrepant diagnoses. When
resolution was not possible two senior physicians working in the
area (FN and NJW) gave the final assignment, if possible.
Malaria was diagnosed based on microscopy of blood slides.
Asymptomatic carriage is unusual in this area of low seasonal
malaria transmission, and invariably associated with low parasit-
aemias, so a positive blood slide is highly specific for malaria as the
cause of febrile illness. Sepsis was defined as severe non-malaria
febrile illness with fever, signs of shock including hypotension,
tachypnoea or anuria These deaths could be further subdivided
into confirmed infection with localizing signs or no localizing signs.
Pregnancy Outcomes
Miscarriage was defined as a pregnancy ending before 28 weeks
gestational age and stillbirth as delivery from 28 weeks or $800 g
birth weight in which the infant displayed no sign of life (gasping,
muscular activity, cardiac activity). The 28-week gestation cut-off,
rather than the current WHO 22 week cut-off was chosen, as no
infant respiratory support is available in the clinics. Preterm births
were deliveries before 37+0 weeks gestational age (GA). Severe
malaria was defined as P.falciparum parasitaemia with signs of
severity such as loss of consciousness or multi organ dysfunction as
defined by WHO. [29] Symptomatic malaria was defined as any
parasitaemia and a history of fever in the last 48 hrs or a measured
temperature $37N5uC [30] and asymptomatic malaria as parasit-
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aemia without fever or history of fever. Severe anaemia was
defined as haematocrit (HCT),20% and anemia as HCT,30%.
Statistical Analysis
Data were analyzed in SPSS for Windows version 19.0 (SPSS,
Inc., Chicago, Illinois, USA) and STATA version 11 (StataCorp,
College Station, Texas USA). Comparisons were made using the
Student’s t-test or Mann Whitney U-test. Categorical variables
were compared using the chi-squared or Fisher’s exact test. To
assess the demographic factors at the first antenatal visit associated
with maternal death trimester, age, weight, parity and anaemia
were examined for all women by univariate logistic regression
analysis. Information on smoking was only gathered routinely
from July, 1997, and migrant consultations commenced in 1998 so
a 2nd analysis was done including women who delivered from 1998
onwards. Multivariable logistic regression analysis was used to
estimate the adjusted odds ratio after accounting for factors
significant (P,0.10) in the univariate analysis.
Results
Between the 12th May 1986 and 31st December 2010 there were
71 maternal deaths recorded amongst 50,982 women who
attended antenatal care at SMRU at least once. Three (4.2%)
were from suicide. Two women, both refugees, aged 36 and 19
years, took antimalarials in overdose including quinine and
chloroquine and one aged 26 years, drank weed killer. These
cases were excluded from all further analyses.
The majority of pregnancies 73.8% (37,612/50,978) were
followed until delivery (live- or stillbirth) 8.9% (4,518/50,978)
miscarried, and for 17.4% (8,848/50,978) the pregnancy outcome
was unknown, usually because the mother left the catchment area.
The majority 72.2% (36,827) of the women attended the clinics in
the refugee camps and 27.8% (14,151) those for migrant women.
Data on whether delivered women had a live- or still-birth were
available for 99.4% (37,403/37,612) of the birth records. Live
births accounted for 98.6% (36,895/37,402) of births. The
estimated maternal mortality ratio (MMR) was therefore 184
(95%CI 150–230) per 100,000 live births over the 25 year period.
Demographic factors at the first consultation associated with
maternal death (Table 1) on multivariate analysis were: being
underweight (weight ,40 kg), anaemic (haematocrit ,30%) and
having a parity of 4 or more. When the analysis was confined to
women who delivered from 1998 (when the data collection of
migrants started) onwards, being underweight (AOR 2.89 (95%CI
1.26–6.62)) and anaemic (AOR 2.12 (95%CI 1.13–3.40)) re-
mained significantly associated with the risk of death.
The median [inter-quartile range] number of antenatal visits,
which is equivalent to the number of screens for malaria, was
significantly lower in women who died compared to those who did
not: 7 [1–29] vs 12 [1–38], p= 0.002l. The proportion of women
with 4 or less antenatal visits was significantly and independently
associated with maternal death for all women: AOR 2.50 (95%CI
1.41–4.43), p = 0.002 and for women who delivered from 1998
onwards: AOR 2.38 (95%CI 1.22–4.64), p = 0.011.
Causes of Maternal Deaths
There were 47.1% (32/68) direct and 52.9% (36/68) indirect
pregnancy related deaths (Table 2). Haemorrhage, sepsis and
P.falciparum malaria were the 3 leading causes of death across all
parity groups. Overall they accounted for 67.6% (46/68) of all
maternal deaths (Table 2). None of the deaths in this series were
from suspected induced abortion. Three antenatal records did not
have enough information to assign a cause of death with
confidence although there was enough information to decide
whether the cause was direct or indirect. HIV testing was available
for 38.2% (26/68) of the women who died and one was confirmed
positive 3.8% (1/26) (Table 2).
Table 1. Demographic characteristics on enrolment associated with maternal death in refugee and migrant women.
Demographics
Did not die
N=50,910 Died N=68
Unadjusted Odds Ratios
[95%CI]; P value
Adjusted Odds Ratios [95%CI],
P value
First ANC visit Trimester 1 24,108 (50.0) 25 (37.9) Reference group Reference group
Trimester 2 or 3 24,083 (50.0) 41 (62.1) 1.64 [1.00–2.70]; P = 0.051 1.58 [0.91–2.72]; p = 0.101
Weight group Normal ($40 kg) 42,630 (93.6) 57 (83.8) Reference group Reference group
Under (,40 kg) 2 911 (6.4) 11 (16.4) 2.83 (1.48–5.39); p = 0.002 2.76 [1.28–5.92]; p =0.009
Age group ,40 years 48,813 (96.1) 62 (91.2) Reference group Reference group
$40 years 1,987 (3.9) 6 (8.8) 2.38 [1.03–5.50]; p = 0.037 1.41 [0.51–3.75]; p = 0.496
Parity group Parity 0 14,471 (28.5) 17 (25.4) Reference group Reference group
Parity 1–3 25,619 (50.5) 23 (34.3) 0.76 [0.41–1.43]; 0.401 0.97 [0.48–1.97]; p = 0.932
Parity .=4 10,640 (21.0) 28 (40.3) 2.16 [1.18–3.96]; 0.013 2.22 [1.06–4.68]; p =0.035
Anaemic 1st visit No 24,543 (58.1) 21 (36.8) Reference group Reference group
Yes 17,719 (41.9) 36 (63.2) 2.27 [1.31–3.99]; 0.003 2.10 [1.20–3.68); p =0.010
Limit‘
Smoker No 25,927 (69.4) 25 (56.8) Reference group Reference group
Yes 11,452 (30.6) 19 (43.2) 1.72 [0.95–3.13]; 0.100 1.36 [0.71–2.59]; p = 0.356
Migrant No 24,424 (63.4) 22 (50.0) Reference group Reference group
Yes 14,128 (36.6) 22 (50.0) 1.73 [0.96–3.12]; 0.082 1.54 [0.84–2.81]; p = 0.164
Missing data: In the Did not die columns - First ANC visit = 2719; weight group n= 5369; age group 110; parity group n = 181; and Anaemic 1st visit n = 8,648. In the Died
column First ANC visit = 2; Anaemic 1st visit = 11. Did not die column for smoker = 1176.
‘Model includes 38,935 women and following ‘‘Limit’’ i.e. data of women who delivered from 1998 onwards, the model includes 34,208.
doi:10.1371/journal.pone.0040244.t001
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Death from Haemorrhage
Death from haemorrhage (N= 19) occurred in the intrapartum
or early post-partum period and included five cases of uterine
atony, four placental abruptions, four cases of ruptured uterus,
three cases of retained placenta, two completed uterine inversions
and one hydatidiform mole (before ultrasound was available).
Three women who died of haemorrhage had a concomitant febrile
illness (all with no obvious focus of infection) but Escherichia coli was
isolated from a blood culture in one hospitalised case. This woman
was a 26 year old, gravidity 3, parity 2, GA 32.0 weeks, referred
with antepartum haemorrhage, placental abruption and dissem-
inated intravascular coagulopathy. Of the 12 women who died at
home 41.6% (5/12) died from haemorrhage.
Death from Sepsis
One of the 15 deaths from sepsis was post-partum, with the
remaining occurred during pregnancy 46.7% (7/15), and intra-
partum 46.7% (7/15). There were 60.0% (9/15) with no localizing
signs. The six cases with localizing sign included: one (probable)
puerperal sepsis (3 days fever), one ruptured amoebic liver abscess;
one sub-xyphoid abscess with two previous abdominal operations;
one suspected Pneumocystis carinii pneumonia in a woman with
tuberculosis and HIV; one dysentery and one case of cholera
(during an epidemic). The length of febrile illness was often
protracted with a median of 10 [1–35] days fever. Only one
woman was attending for the first time and most 64.3% (9/14) had
attended their routine antenatal care consultation within the week
before presenting with sepsis.
Death from Malaria
Maternal deaths from malaria mostly occurred during preg-
nancy without signs of labour: 66.7% (8/12). There were 25.0%
(3/12) intra-partum and 8.3% (1/12) post-partum. All were
P.falciparum and none were P.vivax or mixed infections. There were
83.3% (10/12) of women with coma (1 recovered from coma but
died on day 5 of pulmonary oedema). Two women died from
acidosis and acute severe anaemia with cardio-respiratory failure.
The median duration of fever prior to admission was 4 [2–30]
days. One woman was attending the clinic for the first time and
the remaining 11 women were all absent from their routine
antenatal care visit the previous week. The period of absence was
for a median of 6 [1–14] weeks. Nearly three-quarters, 72.7% (8/
12) died within 12 hours of admission.
Death from Eclampsia and Stroke and Thrombosis
Four primigravidae died from eclampsia. Five multigravid
women died from fatal stroke, three with confirmed essential
hypertension exacerbated by pregnancy and two (both smokers)
presented with a clinical picture consistent with sub-arachnoid
haemorrhage, of which one was confirmed on referral to the Thai
Hospital.
Two women died from suspected fatal thrombosis: one woman
had rheumatic heart disease since childhood and atrial fibrillation
of 10 years duration and died suddenly at a gestation of 16+5 wks.
Another was 33 y.o, gravidity 3, parity 2, who was reportedly well
after an uncomplicated normal vaginal delivery and died suddenly
while walking, on day 4 post-partum.
Death from Other Causes
Four women died from cancer including hepatocellular
(Hepatitis B positive), large bowel, and lung (two cases one of
which was small cell cancer).
Medical complications included: thyroid storm and one case of
chronic respiratory illness with an afebrile exacerbation. There
were two deaths from tuberculosis.
Changes in Maternal Mortality between 1986 and 2010
The maternal mortality in refugee and migrant women remains
higher than reported for Thailand (Figure 2). There has been a six-
fold decline in the overall maternal mortality ratio (MMR) in the
refugee camps from 499 (95%CI 200–780) in 1986–90 to 79 (40–
170) in 2006–10, p,0.05 (Figure 2). P.falciparum malaria related
MMR in the refugee camps fell from an estimated 1,000 per
100,000 (430–2,320) [13] in the year prior to the introduction of
antenatal screening to zero in 2005 and has remained at that level
since (Figure 3a). The sharp fall in maternal mortality due to
P.falciparum occurred with the introduction of weekly screening in
May 1986 and before the decrease in the proportion of women
with P.falciparum in pregnancy (Figure 3a). From 2005–2010 the
Table 2. Causes of direct and indirect maternal death by parity group.
Cause of death Parity 0 N=17 Parity 1–3 N=23 Parity .=4 N=28 Total N=68 (%)
DIRECT DEATHS (obstetric related) 10 9 13 32
Haemorrhage 6 6 7 19 (27.9)
Stroke 0 0 5 5 (7.4)
Eclampsia 4 0 0 4 (5.9)
Fatal thrombosis 0 1 1 2 (2.9)
Unknown 0 2 0 2 (2.9)
INDIRECT DEATHS (aggravated by pregnancy) 7 14 15 36
Sepsis 3 7* 5 15 (22.1)
Severe P.falciparum malaria 4 4 4 12 (17.6)
Cancer 0 2 2 4 (5.9)
Tuberculosis 0 0 2 2 (2.9)
Medical complications 0 1 1 2 (2.9)
Unknown 0 0 1 1 (1.5)
*includes one patient with HIV.
doi:10.1371/journal.pone.0040244.t002
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proportion of women infected with P.falciparum and the proportion
of homebirths have been at their lowest levels.
In migrants the 2.3 fold decline in overall MMR from 588 (100–
3260) in 1996–2000 to 252 (150–430) for the period 2006–2010
was not significant (Figure 2). There was also a reduction in
P.falciparum MMR in the migrants from 588 (100–3,260) in 1996–
2000 to 78 (30–200) in 2006–10 (Figure 3b). Confidence interval
estimates are wide in the early years. P.falciparum related deaths in
pregnant women in this population before the introduction of the
ANC are not available for comparison. The proportion of women
delivering at home has reduced markedly amongst migrant
women as well as the proportion of women with P.falciparum
infection (Figure 3b) as in the general population [31,32]. There is
no obvious relation between home births and P.falciparum related
maternal deaths (Figure 3b).
The maternal mortality of the top 3 causes of death in refugee
(Figure 4a) and migrant (Figure 4b) women were plotted by year
blocks with no significant differences observed.
Outcome for the Newborn
There were 32 women who went into labour and delivered
before dying, of whom 31.3% (10/32) had a stillbirth, a much
higher proportion than amongst the women who did not die, 1.3%
(498/37,370); a relative risk (95%CI) of 32.2 (15.2–68.0),
P,0.001.
The mean gestational age and birth weight of the live born,
singletons in women who died compared to those who did not die
was: 37.6 [31.9–45.0] (n = 22) vs 39.0 [28.0–45.0] weeks,
P = 0.006; and 2657 [1000–4250] vs 2934 [500–5600] grams,
p = 0.402.
Discussion
In a recent review on trends in maternal death in southeast
Asia, using cross-national data sources from 1998–2008, the
major complications of childbirth were: haemorrhage 32%, other
indirect causes 22% (which were proposed to indicate the still-
substantial burden of infectious disease within the region and the
effects of malaria and HIV), hypertension 17%, other direct
causes 10%, abortion 9%, puerperal sepsis 8% and embolism
2%. [33]. In the rural based population described here
haemorrhage (27.9%) was also the most common cause of
maternal death, but indirect causes were responsible for over half
of the deaths (52.9%) and were mainly caused by sepsis and
malaria. The decrease in P.falciparum related MMR was unrelated
to the decrease in home births.
There has been a significant downward trend in pregnancy
related deaths on the Thai-Myanmar border with the most
significant decrease being in deaths from severe P.falciparum
malaria. This is not unexpected given the decline previously
reported in malaria and malaria related deaths in the general
population on the border, but most of the reduction in MMR
occurred before the reduction of malaria incidence in the general
population. [31] The decline in MMR comes some two to three
decades after Thailand made such gains but MMR along the
border still remains significantly higher than reported within
Thailand. [2,8] Pregnant women who develop acute P.falciparum
malaria have little time to obtain appropriate treatment, as the
disease may be fulminant. This is reflected in the short fever
history times (average 4 days) in fatal cases and the short interval
from arrival at the clinic and death. Provision of emergency
obstetric care is unlikely to impact upon this type of presentation.
[34] Only early detection and treatment of malaria in the general
Figure 2. Maternal mortality ratio (95%CI) per 100,000 live births 1986 to 2010. Note the first data point (filled circle) for refugees in the
year prior to 1986 is only P.falciparum as the sole documented contributor to maternal mortality. Subsequent refugee data (open circles) and all
migrant data (open squares) and the 95% confidence intervals (bars) are all cause mortalities, summarized for year blocks. Frequent screening and
early detection and treatment at antenatal care commenced in 1986 in refugees and in 1998 in migrants. The data for Thailand (all cause mortality) is
referenced for discrete years 1986, 1990, 2000 and 2008 (blue bars) and the 95% CI are plotted although they are very narrow [32].
doi:10.1371/journal.pone.0040244.g002
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population, and more specifically frequent screening with early
detection and treatment in the pregnant population, has had a
very significant impact in this area [32]. There is no safe and
effective drug that can be offered as chemoprophylaxis against
P.falciparum and P.vivax because of multidrug resistance. While
weekly screening and early treatment has had a significant
impact in the refugee population, there are still significant rates
of malaria related deaths in the more mobile migrant popula-
tions. Absenteeism from the weekly screens appears to be the
main significant contributor to malaria related maternal death.
This differs from previously published literature which suggests
that a reduced number of antenatal visits does not affect the
overall outcome of pregnancy. [1,35] Four or less antenatal visits
in this setting was significantly and independently associated with
maternal death. Assuming 1% is the ‘normal rate’ of maternal
death from malaria without weekly screening in this area and
50,981 pregnant women have been followed up in ANC at least
once in the 25 years then approximately 509 pregnancy related
Figure 3. Trends in maternal mortality from P.falciparum malaria. Figure 3a Refugees: Prior to 1994 the proportion of homebirths was not
systematically recorded but was estimated at 90% (right axis). From 1994 the place of birth was systematically recorded and a significant decline can
be observed. The fall in maternal mortality due to P.falciparum (left axis) occurred with the introduction of weekly screening in May 1986 and before
the decline in home birth and the decrease of maternal P.falciparum malaria (right axis). From 2005–2010 the proportion of women infected with
P.falciparum and the proportion of home births have been at their lowest with no maternal deaths in the last 5 years. Figure 3bMigrants: Systematic
screening in migrant women started in 1998 and the proportion of women with home births (right axis) has reduced markedly as well as the
proportion of women with P.falciparum infection (right axis). There does not appear to be a relation between home birth and P.falciparum related
maternal deaths (left axis).
doi:10.1371/journal.pone.0040244.g003
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malaria deaths have been averted. Unfortunately, malaria related
maternal mortality, a highly preventable illness, remains a
significant problem in the South-east Asia region. [36] Insecticide
treated bednets are unlikely to be a useful preventive strategy in
this population [17–19].
Figure 4. Three major causes of maternal mortality in refugees and migrants on the Thai-Myanmar border. Maternal mortality rates for
haemorrhage (black square), sepsis (open square) and P.falciparum (grey square) are presented in year blocks for Figure 4a refugees and Figure 4b
migrants. The 1996–2000 year block in migrants represents data collection commencing in 1998.
doi:10.1371/journal.pone.0040244.g004
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Sepsis was one of the leading causes of maternal death.
Unfortunately microbiological diagnosis was unavailable for the
majority of the study period. Unlike women who died from
P.falciparum malaria these women were mostly present at their
routine antenatal clinic before presenting with the terminal illness.
The fevers were generally protracted. One of the deaths in this
cohort was reported in a study which offered full blood count,
malaria smear, haemoculture, urine culture, rickettsia, leptospiro-
sis and dengue investigations, but no causative agent was identified
[18,37,38]. More sophisticated testing will be required to elucidate
the cause of death in such cases. There has been no trend over
time towards a reduction in this cause of pregnancy related death.
Unlike recent reports from Sub-Saharan Africa, HIV is not a
major cause of maternal death in this area. [39] Part of the reason
for this relates to the very low rate of HIV within the population
and the use of HAART for all HIV positive pregnant women since
2001 in the refugee population and 2008 in the migrant women.
The culture of the Karen ethnic group from eastern Myanmar
[22] is likely to have provided some protection from the HIV
epidemic within the country but this may not apply to other rural
areas in Myanmar [40].
In contrast to most previously published data no deaths from
septic abortion were seen and the rate of puerperal sepsis was also
very low. [41] Of note is that induced abortion was not a
significant contributor to maternal death in this area as reported
for a clinic servicing migrant women in an urban setting in Mae
Sot, a distance of just 25 to 60 kilometers from the SMRU clinics
[23].
The factors associated with death in this study (body weight less
than 40 kg, parity of four or more and anaemia at the first
consultation) are all potentially modifiable by appropriate inter-
ventions such as family planning, nutritional support programs,
and information and education. A limitation of this observational
study is definitive data on place of birth for all records as well as
smoking data prior to 1998.
In total 17.4% of women were lost from follow-up, after
enrolment to antenatal care and before delivery outcome, usually
returning to Myanmar. In refugee and migrant women clinics that
predominantly provide services to women from Myanmar the
maternal mortality ratio is still unacceptably high and most likely
underestimated: currently 79 (40–170) and 252 (150–430) per
100,000 live births in 2006–10, respectively. The MMR in the
refugee camp is approximately 1.7 fold higher than reported for
Thailand 47 (42–53)in 2008. [7] Unlike deaths from haemorrhage
that are easily linked to labour and delivery, malaria and sepsis
may well remain a hidden cause of maternal death as they mostly
occur in women without labour, which decreases the likelihood
that the death is recorded as pregnancy related.
Measurement of maternal mortality is seldom undertaken in
refugee and migrant women or in the rural tropics and the data
presented here is limited by the unavailability of laboratory
microbiology and of autopsy. The malaria related deaths were
confirmed by microscopy. Sepsis and P.falciparum malaria are
significant contributors to pregnancy related death on the Thai-
Myanmar border. P.vivax malaria is not. The causes of maternal
mortality are not universal and decisions on how to reduce
mortality require robust local evidence. Early detection and
treatment of malaria with frequent screening in pregnancy has had
a profound impact on malaria related maternal deaths on the
north-western border of Thailand.
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